The specific RNA-protein interactions responsible for the production of mature 3′ ends of eukaryotic mRNAs are not well understood. Sequence elements at the 3′ ends of yeast genes have been identified that specify the position of the poly(A) site and the efficiency of polyadenylation. To provide additional insights into the interaction between important sequences that direct 3′-end formation in vivo and nuclear proteins, we utilized gel mobility shift assays and UV-crosslinking studies. The data indicate that a protein, with an apparent molecular weight of 80 kDa, interacts specifically with pre-mRNA at the (UA) 3 efficiency element. Although the interaction is specific, it can be competed by RNA sequences that do not contain the same type of efficiency element; that is, a sequence lacking a (UA) 3 repeat. This result implies that the protein binding site is flexible. Using immunoprecipitation techniques, the protein has been identified as Hrp1, a heteronuclear RNA binding protein. The role of Hrp1p in 3′-end formation including RNA processing and transcription termination is addressed.
INTRODUCTION
The 3′ ends of eukaryotic mRNA are marked by a polyadenylate [poly(A)] tail. The poly(A) is added onto the pre-mRNA posttranscriptionally as a result of a two step process: endonucleolytic cleavage of the pre-mRNA followed by the polymerization of the adenylate residues (for reviews see 1,2). Significant progress has been made in understanding the machinery that directs these pre-mRNA processing events in vitro. In both mammalian cells and yeast, the cleavage and polyadenylation reactions can be performed using pre-mRNA substrates and cellular extracts (3, 4) .
In yeast, additional genetic approaches have been utilized to identify components of the processing machinery (5) (6) (7) (8) (9) . Taken together, the current understanding of the cleavage reaction indicates that three factors (CF IA, CF IB and CF II) are required (10, 11) . The proteins that constitute each factor have been identified and many are homologous to proteins identified in mammalian cells. The polyadenylation reaction is also well understood. The poly(A) polymerase (PAP) has been identified from both mammalian cells and yeast (12, 13) . In yeast, in addition to PAP, a polyadenylation factor I (PF I), a poly(A) binding protein (PAB I), and a third factor, CF I, are required for poly(A) addition. The identification of the components of the processing reactions is a first step toward understanding the mechanism by which the processing machinery recognizes the poly(A) site and allows the poly(A) polymerase to add the tail onto the mature end of the mRNA.
In order to fully understand the mechanism of 3′-end formation it is also necessary to identify the cis-acting signals that determine the site of cleavage and polyadenylation, as well as the efficiency of this process. A comparison of sequences surrounding the poly(A) site of a large number of yeast genes does not reveal a highly conserved signal for cleavage and polyadenylation. However, mutational analysis revealed that a tri-partite signal exists at the ends of yeast genes (14, 15) . This signal consists of an element that influences the efficiency of the reaction (usually a UA-rich element), followed by a sequence that directs the position of the cleavage (usually an A-rich element), followed by the poly(A) site itself (usually PyA). Although not found uniformly in all yeast genes in this simple arrangement, a synthetic signal consisting of the efficiency, positioning and poly(A) site elements is necessary and sufficient to direct 3′-end formation in vivo.
Insight into the role of the efficiency element has recently been gained by the demonstration that a GST-Hrp1 (heterogeneous nuclear ribonucleoprotein, the sole component of CF IB) fusion protein binds to a pre-cleaved RNA in vitro at the UA element, which is essential for 3′-end formation in vivo (16) . Additional proteins such as RNA 15p, and the 105 kDa protein in CF II, can also interact with the 3′-end RNA sequence (5, 10, 11) . Although the RNA 15p binding site is unknown, the 105 kDa protein interacts with a UA-sequence in pre-mRNA only in the presence of ATP. It is not clear why both GST-Hrp1 and 105 kDa proteins binds the same UA element in vitro.
Although much has been learned regarding the mechanism of RNA processing at the 3′ end using in vitro assays, it is important to note that in these studies, the RNA processing events are uncoupled from transcription by RNA polymerase II. However, several lines of evidence suggest that transcription and 3′-end formation are coupled to each other in vivo. For example, in the absence of termination, downstream promoter elements may be adversely affected by readthrough from an upstream promoter (17) (18) (19) (20) . Mutation of the cis-acting signal, critical for cleavage and polyadenylation in mammalian cells and yeast results in aberrant termination of transcription by RNA polymerase II (21) (22) (23) (24) . However the most direct evidence for coupling of the processing machinery with transcription termination comes from two recent observations. First, mutations in the known yeast processing factors Rna14, Rna15 and Pcf11 result in increased readthrough transcription (25) . Secondly, processing factors, including those that constitute the mammalian CPSF (cleavage and polyadenylation specificity factor) are associated with the phosphorylated C-terminal domain of RNA polymerase II (26) (27) (28) . This suggests a model whereby processing factors are loaded onto the polymerase early in the transcription process, and 'unloaded' following synthesis of the polyadenylation signal at the end of a gene.
In order to fully examine the process of 3′-end formation, we reasoned that an in vitro system that is competent in transcription and 3′-end formation may provide new insights into the mechanism of 3′-end formation. In contrast to the highly purified protein factors that process exogenously added pre-mRNA, nuclear extracts synthesize the pre-mRNA de novo, and may utilize factors that are specific to both polyadenylation and transcription termination. Using nuclear extracts, we demonstrated previously that RNA polymerase II recognizes termination sites, resulting in the production of transcripts that end ∼100 nt downstream of the polyadenylation site (24) . These transcripts are not polyadenylated and are suggestive of a pre-mRNA product of transcription that is neither cleaved nor polyadenylated. For this reason, we have chosen to examine the RNA-protein interactions important for 3′-end formation and transcription termination in a system that may more closely mimic the events that occur in vivo.
MATERIALS AND METHODS

Reagents and enzymes
Protease K, RNasin, rNTP, dNTP, and all restriction enzymes were purchased from Promega. Vent DNA polymerase, T4 DNA ligase and Klenow fragment were from New England Biolabs. T1 RNase was from Boehringer Mannheim. RNase A was from Sigma. [ 32 P]UTP was from Amersham. All chemicals were supplied by Fisher. Plasmid pT7T319U was from Pharmacia.
Plasmid construction
Plasmid pL101 and ADH2 3′-end sequence was described previously (23) and is shown in Figure 1A . The plasmid pBEVY-U (Fig. 1A) was kindly provided by Dr Charles Miller and described (29) . It is a yeast 2 µm plasmid containing two promoters for bi-directional cloning and expression in yeast. One promoter, from the ADH1 gene, is followed by the ADH2 3′ termination. The other promoter GPD is followed by the ADH1 3′ termination signal. This ADH1 3′-end sequence is sufficient for 3′-end formation and has been described previously (30) . Plasmid p1GA (map not shown) was constructed on the basis of pBEVY-U by removing the ADH2 3′ end using SmaI and XhoI, filling in the ends with Klenow fragment and ligating the blunt ends with T4 DNA ligase. Plasmid pGA101 (map not shown) was made by inserting the BamHI-XhoI ADH2 3′-end fragment (amplified by PCR with restriction enzyme-containing site primers PM1, 5′-GCGCTGCAGGATCCGACACTTCTAAAT-AAGCGG-3′ and PM2, 5′-CCGCTCGAGGGCATGCGAAG-GAAAATGAG-3′) into BamHI-SalI sites of p1GA. Therefore, ADH 2 3′ end was located between the GPD promoter and the ADH1 3′ end in plasmid pGA101. Plasmid p2GA was obtained by removing the ADH1 3′ end from pGA101 using PstI and PvuII, filling in the ends and ligating the blunt ends. Plasmid pL407 is the same as pL101 except that the ADH2 3′ end contains TATATA(74-79) element deletion. Plasmid p2GAdel(TA) 3 is the same as p2GA except that the ADH2 3′ end contains TATA-TA(74-79) element deletion.
Synthesis of ADH2 3′ end antisense probes
The oligodeoxynuclotides PM3, 5′-GACACTTCTAAAT-AAGCGG-3′; PM4, 5′-GCGCTAATACGACTCACTATAG-GGCAAACGCGGTGGGAGC-3′; PM5, 5′-GTGTTCGTTAT-GTACGGC-3′; and PM6, 5′-GCGCTAATACGACTCACTAT-AGGGCATGCGAAGGAAAATG-3′ were synthesized. The underlined DNA sequence is the T7 promoter. The template for synthesis of ADH2 3′-end antisense RNA probe A (Fig. 1B) was made by amplifying upstream ADH2 3′ end with primers PM3 and PM4. The template for synthesis of ADH2 3′ end antisense RNA probe B (Fig. 1B) was made by amplifying downstream ADH2 3′ end with primers PM5 and PM6. The PCR fragments were transcribed by T7 RNA polymerase in the presence of [ 32 P]UTP and RNAs were purified.
Yeast transformation
Plasmids pL101, pL407, p1GA, p2GA and pBEVY-U were transformed into yeast strain YPH 98 (MATa ade2-101 lys2-801 ura3-52 trp1-1 leu2-1). Yeast transformation was performed as described (31) . Cells were streaked onto complete minimal media plates without uracil and with dextrose (CM-URA DEX plates).
Yeast total RNA preparation, northern blot analysis and RT-PCR mapping of mRNA poly(A) sites
Yeast cells containing p1GA, p2GA and pBEVY-U were grown in 5 ml of CM-URA Dex to an OD 600 of ∼0.8-1.0. Yeast cells containing pL101 and pL407 were grown in 5 ml of complete minimal media without uracil and with galactose to an OD 600 ∼0.5. Yeast total RNA was prepared according to the described protocol (32) . RNAs were separated by electrophoresis on 1.5% agarose-formaldehyde gels and northern analyses were carried out as described (23) . Mapping the 3′ ends of mRNAs was described previously (33) .
Preparation of yeast nuclear extracts and in vitro transcription
Yeast nuclear extracts were prepared from strain BJ926 (MATa/a trp1/+prc1-126/prc1-126 pep4-3/pep4-3 prb1-1122/prb1-1122 can1/can1) as described (34) . The resulting nuclear extracts were stored at -80_C. Protein concentration was determined using Bio-Rad protein assay. For each in vitro transcription reaction, 130 µg of extracts and 0.5 µg supercoiled DNA template were incubated in a total volume of 50 µl. The in vitro transcription reaction and RNA extraction were described previously (35) . In vitro transcribed RNAs were analysed by northern blot. 
Synthesis of different RNA fragments
DNA templates for synthesizing each ADH2 3′ end RNA fragment were made using PCR with a 5′ sense primer containing the T7 promoter sequence and a 3′ antisense primer. RNA probes were labeled with [ 32 P]UTP during in vitro transcription, and RNA competitors were transcribed in the absence of [ 32 P]UTP. For making sense ADH1 RNA fragment A, the PstI-DraI ADH1 3′-end fragment from pBEVY-U (Fig. 1A ) was cloned into PstI-Sma I cleaved vector pT7T319U. The new plasmid pT7T319UADH1 3′ end was cut by EcoRI and transcribed by T7 RNA polymerase to synthesize sense ADH1 RNA fragment A. In order to make the ADH1 RNA fragment B for UV-crosslinking study, primers 324T7 (5′-GCGCTAATACGACTCACTATAGG-GTTGACACTTCTAAATAAG-3′) and 325 (5′-AAATTTGTA-TACACTTA-3′) were used to amplify template ADH1 3′ end in plasmid pBEVY-U. The PCR fragments containing 87 bp just upstream of poly(A) sites (30) were transcribed by T7 RNA polymerase. Both ADH1 RNA fragments A and B contain the cis-acting sequences upstream of poly(A) site (30), but ADH1 RNA fragment A is longer. All RNA probes and competitors were purified by electrophoresis in 5% acrylamide-7 M urea gels, overnight elution at 24_C in 0.5 M ammonium acetate, 1 mM EDTA, and 0.1% SDS, followed by phenol extraction and ethanol precipitation.
Gel mobility shift assay
RNAs were incubated for 15 min at 24_C with 90 µg of nuclear extracts in a 20 µl mixture using the in vitro transcription conditions (35) . Optimization of the reaction included: varying the pH (range 6.9-8.1); the K acetate (0-70 mM); and the MgSO 4 , MgCl 2 , NaCl and KCl (0-100 mM). The absence of Mg acetate had no effect on specific RNA-protein binding. The final reaction mixture contained 10 mM HEPES (pH adjusted by KOH to 7.8), 0.025 mM of each rNTP, 3 mM MgSO 4 , 3 mM MgCl 2 , 5 mM EDTA, 2.5 mM DTT, 20 U RNasin, 5 µg tRNA, 10% glycerol and 90 µg yeast nuclear extracts. Competition assays were performed by mixing 32 P-labeled RNA with 20-, 40-, 80-, 160-, 320-and 640-fold molar excess of unlabeled competitor RNAs prior to the addition of nuclear extracts. The reaction mixtures were run on a 5% polyacrylamide (60:1)-1× Tris-glycine gel at 4_C. Gels were dried and visualized by a conventional autoradiography or by a PhosphorImager.
UV-crosslinking
RNAs were incubated with 90 µg as described above for the gel mobility shift assay. After binding, each mixture was digested with 60 U RNase T1 at 24_C for 15 min and subsequently exposed to short wavelength UV light (254 nm) on ice at a 6 cm distance for 40 min. Samples were digested with 25 µg RNase A only or with 25 µg RNase A and 3 µg proteinase K for 15 min at 37_C and analyzed by 10% SDS-PAGE. The gel was dried and subjected to autoradiography or visualized by scanning the gel with a PhosphorImager.
Immunoblotting
18 µg yeast nuclear extracts and 0.14 µg H6Hrp1 were separated on a 10% SDS-PAGE, blotted and immunostained with mouse polyclonal antibodies against H 6 Hrp1. Immunoblots were carried 
Immunoprecipitation
Immunoprecipitation (IP) was performed following the protocol described by Santa Cruz Biotechnology, Inc. Briefly, after UV-crosslinking and RNase A digestion, Buffer IP (1× PBS, 0.01% NP40, 0.1% SDS) was added to each tube and mixed. Subsequently, 1 µl anti-Hrp1 mouse serum or 1 µl pre-immune mouse serum was added and incubated at 4_C for 1 h; 20 µl protein A agarose (Santa Cruz) was incubated with 180 µg yeast nuclear extracts in 200 µl Buffer IP at 4_C for 30 min. The beads were collected by centrifugation and mixed with each sample. The reactions were incubated at 4_C for 1 h. Immunoprecipitates were collected by centrifugation, the pellet washed twice with buffer IP, repeating centrifugation steps as above. After final wash, the pellet was resuspended in 40 µl 1× electrophoresis sample buffer.
RESULTS
The effect of the (UA) 3 deletion on 3′-end formation in vivo
Previous studies have demonstrated that the sequences located at the end of the ADH2 gene constitute a strong termination signal (23, 24) . By examining a 327 nt fragment inserted within an intron in a chimeric gene linked to LacZ (Fig. 1A) , we determined that transcription termination occurs with high efficiency (95% termination) at the ADH2 3′ end. Four point mutations were identified within the terminator sequence that resulted in 
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decreased efficiency of termination of transcription. However, these mutations are located upstream of the presumptive efficiency and positioning elements described by Guo and Sherman (15) . To determine if the ADH2 termination site utilizes an unusual signal or contains a consensus-like efficiency element, we examined the effect of a deletion of a (UA) 3 sequence, a good candidate for the efficiency element in the ADH2 3′ end. Deletion of this efficiency element (pL407) results in increased readthrough in vivo as indicated by the production high levels of β-galactosidase activity compared with cells containing the wild-type plasmid (data not shown). RNA isolated from cells containing the wild-type plasmid (pL101) or the plasmid containing the efficiency element deletion (pL407) was analyzed by northern blotting using an ADH2 3′-end antisense probe A, as shown in Figure 1B , and the predicted terminated transcript was seen only in wild-type cells (Fig. 1C, lanes 1 and 2) . Thus, the (UA) 3 sequence is required for 3′-end formation in vivo.
The effect of the ADH2 3′ end context on the choice of its poly(A) sites
A major feature of the chimeric gene used to access termination efficiency is the presence of the 3′-end formation signal within an intron. To test if the terminator context might have effects on mRNA 3′-end formation, we utilized two new templates in which the intron is removed and transcription is driven either by the GPD or the ADH1 promoter (see Fig. 1A for a comparison of these plasmids). In addition, as the promoters are different in all three plasmids, we can determine if selection of the poly(A) site is influenced by the promoter. RNA was isolated from cells containing the plasmids pL101, pBEVY-U and p2GA, and subjected to northern blot analysis as shown in Figure 1C . Note that within the p2GA context, a deletion of the same (UA) 3 efficiency element also results in complete readthrough (lanes 3 and 4). To establish if the polyadenylation sites are the same in both the pL101 context and the pBEVY context, RT-PCR was used to generate the appropriate DNA fragments that were then cloned and sequenced. The results of this analysis are shown in Figure 1D , and demonstrate that the poly(A) tail is added onto the pre-mRNA at the same region within the ADH2 3′-end sequence regardless of the intron context of the terminator. In contrast, RNA from cells containing p2GA contain a major and a minor species (not mapped). The difference between the poly(A) site selection may be promoter specific or due to contextual effects.
In vitro transcription assay using different promoters
In addition to the ability of the ADH2 3′-end signal to direct efficient termination in vivo, we have also shown that RNA polymerase II recognizes the sequence during in vitro transcription and generates RNA that is ∼100 nt longer than the same RNA synthesized in vivo. The template used for that study was the supercoiled plasmid, pL10l. As the transcription extracts are prepared from cells grown under repressing conditions (i.e. in dextrose), the resulting transcription presumably reflects a basal level of activity. Given that the promoter in the pL101 plasmid is regulated by galactose induction, we reasoned that we might improve upon the yields in this reaction if we utilized a new template that contains the same termination sequence driven by the constitutive, highly expressed GPD promoter. To test the promoter effects on the efficiency of the transcription reaction, we compared RNA synthesized in vitro off both types of templates. Indeed, the p2GA template directs the transcription of the ADH2 terminated transcript more efficiently compared with the pL101 template, as shown in Figure 2A (compare lanes 2 and 3 with lanes 5 and 6). Quantitation of the signals seen on northern blots demonstrate an increase in the ADH2 signal of ∼3-fold.
A specific RNA-protein interaction in the nuclear extracts
Having established that the in vitro transcription reaction mimics the events that occur in vivo, we reasoned that we might utilize these extracts to provide additional insights into the relationship of a transcriptional termination sequence with specific nuclear proteins. In order to investigate specific RNA-protein interactions we utilized an RNA gel mobility shift assay. We focused on that part of the 327 nt RNA fragment that contained the most likely candidates for valid efficiency and positioning elements within the ADH2 termination sequence. We optimized the RNA substrate for binding by testing several overlapping fragments of the ADH2 3′-end sequence. 32 P-labeled RNA was prepared corresponding to each of the fragments shown in Figure 3A . Primers containing the T7 promoter sequence were combined with gene-specific sequences to generate PCR fragments that would serve as a template for T7 RNA polymerase. To assess the specificity of the RNA-protein interaction, both wild-type and mutant RNAs were synthesized. The mutant RNAs contained a previously described U60G mutation (23) or the deletion of the (UA) 3 sequence, either of which had a clear negative effect on 3′-end formation in vivo. Each fragment was then tested for the ability to bind to protein from the nuclear extract under the same conditions used for the transcription reactions. Of the nine different RNAs tested in the gel shift assay, no differences between the wild-type and the mutants were observed between fragments A and B or C and D (data not shown). However, fragment E clearly showed a specific gel-shifting pattern that was eliminated in the comparable fragment containing the (UA) 3 deletion (fragment F, Fig. 3B) . Fragment E contains ADH2 3′-end sequences from position 50 to 154, including the efficiency element. To localize the protein binding site(s) further, truncated RNAs were synthesized (Fig. 3A, fragments G-I) . Only fragment I, containing the (UA) 3 repeat, showed a unique gel-shifting pattern establishing that the protein binding site is present within this sequence (Fig. 3B) .
To confirm these observations we optimized conditions for binding of protein to the E RNA fragment. Specifically, the parameters for pH, salt concentrations (MgCl 2 , KCl, NaCl, MgSO 4 , and K-and Mg-acetate), were determined as described in Materials and Methods (data not shown). Upon optimization, the RNA-protein interaction was very clear, as shown in Figure 3C . These conditions were utilized for all further experiments.
We reasoned that if the RNA-protein interaction we observed was indeed specific, then the gel-shift pattern should be competed by wild-type RNA (RNA corresponding to fragment E), but not by RNA containing a mutation that eliminates 3′-end formation in vivo (RNA corresponding to fragment F). Thus, competition experiments were performed whereby unlabeled RNA was added in increasing amounts to the reaction mix. As shown in Figure 4 , the unlabeled wild-type RNA competes with the labeled probe for protein binding; in contrast, unlabeled RNA containing the (UA) 3 deletion does not compete, even when present in 640-fold molar excess. Taken together with the observation that a RNA binding 
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substrate containing the (UA) 3 deletion does not allow formation of a gel shifted species, we conclude that the (UA) 3 sequence is necessary for pre-mRNA to interact with a protein present in the nuclear extract that may be required for 3′-end formation in vivo.
An 80 kDa protein detected by UV-crosslinking
To establish what protein is responsible (at least in part) for the gel mobility shift, a series of UV-crosslinking and immunoprecipitation experiments were conducted. In this set of experiments, the radiolabeled RNA was added to nuclear extracts under the optimal binding conditions determined for the gel mobility shift assay. After binding, samples were treated with RNAse T1, which digested the sequence around the UA element, and exposed to UV light, as described in Materials and Methods. After irradiation, samples were treated with RNase A, and examined by SDS-PAGE. The results are shown in Figure 5A . If the starting RNA substrate contained the UA sequence, an 80 kDa protein was detected, along with other non-specific proteins (lanes 1 and 2) . However, when the (UA) 3 sequence was deleted (lanes 3 and 4), this 80 kDa protein did not bind to the mutant RNA, suggesting that the 80 kDa polypeptide binds at the UA sequence. As a GST-Hrp1p fusion protein has been shown to interact with a UA repeat present in the 3′ end of the GAL7 mRNA (16), we next examined the possibility that this is the same protein that we are detecting in our UV-crosslinking assay.
To establish if the 80kDa protein is Hrp1p , we utilized a polyclonal antibody raised against purified Hrp1p to immunoprecipitate extracts that have been subjected to the UV-crosslinking. As shown in Figure 5B , the specific crosslinked protein is precipitated by anti-Hrp1p antibodies. Thus, we conclude that the protein responsible for the mobility shift and the specific interaction with the (UA) efficiency element is indeed Hrp1p.
Finally, to further extend our analysis, we used this antibody for western blot analysis on nuclear extracts. Interestingly, we detected two Hrp1p species (a major species of 79.5 kDa and a minor species of 77.3 kDa; Fig. 5C, lane 1) . The recombinant H 6 Hrp1 was used as a positive control (84 kDa; Fig. 5C, lane 2) . Although the molecular mass of Hrp1 is slightly higher than that reported for Hrp1p (73 kDa), in our hands, recombinant Hrp1p (calculated molecular mass, 76 kDa) also migrated appropriately higher.
Hrp1p binding specificity
To determine if the protein interaction with the ADH2 3′-end sequence is specific to only this terminator, or is a more universal factor interacting with other efficiency elements, we asked if a different 3′-end signal could compete for binding with the ADH2 3′ end. To address this point, we examined the ADH1 sequence as the ADH1 and 2 genes are diverged within this region of the non-coding regions. We examined the ADH1 3′-end sequence for two reasons. First, it is as efficient a termination signal as the ADH2 3′-end sequence in vivo. Secondly, examination of the sequences known to be important for directing 3′-end formation in the ADH1 gene do not reveal a UA repeat (or any of the accepted variations of this efficiency element) sequence. Thus, this gene does not seem to conform to the generalized processing signals found in many other yeast 3′ ends. If the ADH1 3′-end signal operates via a different mechanism for 3′-end formation, it should not effectively compete for binding with the ADH2 3′-end sequence. As shown in Figure 6A , the ADH1 3′ end competes effectively with the ADH2 3′-end sequence in a gel mobility shift assay.
To demonstrate directly that the competition with ADH2 is due to Hrp1p binding, we performed a crosslinking experiment utilizing radiolabeled ADH1 RNA in the presence of non-specific RNA. As shown in Figure 6B , the same 80 kDa protein that binds to ADH2 RNA also binds to ADH1 sequences. Finally, purified H 6 Hrp1p can also be crosslinked to the ADH1 sequence in the presence of non-specific RNA in a manner analogous to ADH2 binding, albeit with reduced efficiency (Fig. 6C) . Thus, from these experiments we conclude that although the two signals 
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contain different efficiency element sequences, they interact with the same protein factor, Hrp1p.
The effect of the (UA) 3 deletion on transcription termination in vitro
We have demonstrated a specific RNA-protein interaction within the 3′ end of yeast mRNAs; however, it is not clear if the 80 kDa protein we are detecting is important for 3′-end processing, actual transcription termination or both. As noted, the two processes of polymerase dissociation (transcription termination) and RNA processing (cleavage and polyadenylation) are tightly linked in yeast and in mammalian cells in vivo making it difficult to study the individual reactions separately (21, 22) . However, we can study both processes separately, in vitro. The UA element is required for 3′-end processing using cellular extracts (37). As we have now identified a protein that interacts with pre-mRNA at the efficiency element, we wanted to determine if a mutation in the sequence directing this interaction would effect transcription termination. To address this point we utilized an in vitro transcription assay. Two sets of templates were examined for transcription in vitro. The first contained the wild-type ADH2 sequence (Fig. 7A, lanes 2 and 3) ; the second contained the (UA) 3 deletion (Fig. 7A, lanes 4 and 5) . After in vitro transcription, RNA was isolated and examined by northern blot analysis using an ADH2 3′-end antisense probe A (Fig. 1B) that detects RNA product. From the data shown in Fig 7A, it is clear that there is little difference in the transcription pattern for the two templates. Confirmation of this result was obtained when the p2GA and its mutant derivative plasmid were used as a template for in vitro transcription (Fig. 7B) . In Figure 7B , ADH2 3′-end antisense probe B (Fig. 1B) was used. This probe is designed to detect the high molecular weight species of in vivo and in vitro RNAs as shown in Figure 2 , lanes 4 and 5. However, in vivo, the (UA) 3 deletion results in complete readthrough (Fig. 1C, lanes 2 and 4) . The difference between the in vivo and in vitro results allows us to conclude that the efficiency element is important for 3′-end formation because it directs the proper cleavage of the pre-mRNA transcript but it does not have an effect on the transcripts that we detect in vitro. This may mean that the in vitro synthesized RNAs are not the result of truly terminated transcript, but rather may reflect a pausing of the polymerase that, in vivo, can resume transcription.
DISCUSSION
In this report we demonstrate that an 80 kDa protein interacts with a yeast 3′ pre-mRNA at the efficiency elements of yeast polyadenylation signals. This interaction was revealed utilizing gel mobility shift assays and UV-crosslinking in crude nuclear extracts, methodologies that had not previously been successful in identifying specific interactions involved in mRNA 3′-end formation in yeast. Due to the complexities of the transcription and processing machinery, we reasoned that we might detect interactions that more closely resemble activities present in the nucleus if we used nuclear extracts, as opposed to purified components. Earlier work identified two purified proteins that specifically interacted with the (UA) efficiency element: GST-Hrp1 (99 kDa) and Cft2 (105 kDa). In utilizing yeast nuclear extracts that more closely resemble the in vivo situation, we examine In vitro transcription using templates p2GA and p2GAdel(TA) 3 . Lanes 1 and 2, 5 µg RNAs extracted from yeast cells containing plasmids p1GA and p2GA, respectively. The p1GA does not contain ADH2 3′-end fragment and was used as negative control; lanes 3 and 4 (identical reactions), RNAs extracted from in vitro transcription using template p2GA; lanes 5 and 6 (identical reactions), RNAs extracted from in vitro transcription using template p2GAdel(TA) 3 ; lane 7, RNAs extracted from in vitro transcription without template and used as a negative control for northern analysis. The ADH2 3′-end antisense probe B was used to detect the high MW species of RNA shown in Figure 2 , lanes 4-6.
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RNA-protein interaction at the UA element. The protein that we have identified is Hrp1p. Interestingly, although the ADH1 3′-end signal does not contain any of the UA-like efficiency elements determined by mutational analysis, it can compete for binding with the ADH2 3′-end signal, which does contain this consensus-like sequence. This suggests that the Hrp1p binding site is not strictly sequence specific, as it appears to bind to non-consensus efficiency elements. Thus, the same factor may recognize different sequences. This may account for the observation that cis-acting signals for 3′-end formation are not highly conserved in yeast. The mechanism of transcription termination by RNA polymerase II is complicated by the fact the mRNA does not end at the poly(A) site, but rather is generated by processing of a pre-mRNA. It is likely that once RNA polymerase transcribes past the site that will become the poly(A) tail, three interrelated events must occur: release of the enzyme from the template, cleavage of the nascent RNA, and polyadenylation. Several lines of evidence suggest that the release of the RNA polymerase II enzyme from the template is dependent on the cleavage event. For example, mutations that result in loss of cleavage activity also result in increased readthrough transcription (25) and mutations in the mammalian poly(A) signal result in aberrant transcription termination in vivo. Taken together, these results suggest that if the poly(A) site is not recognized, the transcription reaction will not terminate efficiently (21, 22) . However, recent work suggests that although polyadenylation signals may be required for termination, they are not sufficient to direct the release of RNA polymerase. The polyadenylation signals may work in concert with downstream elements (DSE) to pause RNA polymerase prior to the cleavage event (38, 39) . The data presented here support this hypothesis in that, in vivo, the (UA) efficiency element is clearly required for functional 3′-end formation, yet the in vitro results suggest that terminated transcripts are generated even in the absense of cleavage. It is possible that in the in vitro system, RNA polymerase pauses at a DSE, generating the pre-cleaved transcripts that are observed, but in vivo these are 'chased' into readthrough transcripts in the absence of cleavage. Alternative explanations include the possibility that the in vitro system is lacking important factors that may function in coupling the two reactions.
It is also interesting that different yeast genes appear to have different sequence requirements for transcription termination. For example, the 3′-end formation signals for the FBP1 gene resemble the ADH2 signal; in both genes, deletion of the efficiency element does not impair transcription termination or polymerase pausing. The assays used to examine the FBP1 gene, transcription run-on analysis and plasmid instability assays, suggest that actual termination of transcription does occur in the absence of an efficiency element (40) . Yet, other well-studied sequences, including the CYC1 signal, appear to be dependent on the (UA)-like efficiency element for their termination activity in vivo (25, 41, 42) . This raises the possibility that there are two types of signals directing 3′-end formation in yeast; the complex signal(s) such as those present in ADH2 and FBP1 and the more compact signal found in GAL7 and CYC1. Whether these differences are inconsequential or reflect a regulatory function remains to be determined.
